Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Moore

Showing results (1311-1320 of 1,421) with videos related to

Pageof 143
Sort By:
Viruses|January 18, 2019
Clinical Characterization of Host Response to Simian Hemorrhagic Fever Virus Infection in Permissive and Refractory Hosts: A Model for Determining Mechanisms of VHF PathogenesisJoseph P Cornish, Ian N Moore, Donna L Perry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline UpdateStéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong, et al.
Gynecologic Oncology|January 3, 2009
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomesAmanda Nickles Fader, Christa Nagel, Allison E Axtell, et al.
Gynecologic Oncology|January 15, 2019
Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trialMichel Fabbro, Kathleen N Moore, Anne Dørum, et al.
Gynecologic Oncology|April 26, 2025
Impact of adding the immune checkpoint inhibitor atezolizumab to first-line chemotherapy on progression-free survival in poor-prognosis ovarian cancer: A retrospective analysis from the IMagyn050 trialBenoit You, Charles Anderson, Sabrina Chiara Cecere, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Zarna Rajeshkumar Pala, Thiago Luiz Alves E Silva, Mahnaz Minai, et al.
Frontiers in Pharmacology|May 1, 2024
The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat modelAmy L Inselman, Elysia A Masters, Jalina N Moore, et al.
Frontiers in Oncology|February 28, 2022
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b StudySara M Tolaney, Muralidhar Beeram, J Thaddeus Beck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2020
Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 TrialPaul DiSilvestro, Nicoletta Colombo, Giovanni Scambia, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 17, 2023
Low-grade serous ovarian cancer: expert consensus report on the state of the scienceRachel N Grisham, Brian M Slomovitz, Nicole Andrews, et al.
Pageof 143

Showing results (1311-1320 of 1,421) with videos related to

Sort By:
Pageof 143
Viruses|January 18, 2019
Clinical Characterization of Host Response to Simian Hemorrhagic Fever Virus Infection in Permissive and Refractory Hosts: A Model for Determining Mechanisms of VHF PathogenesisJoseph P Cornish, Ian N Moore, Donna L Perry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline UpdateStéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong, et al.
Gynecologic Oncology|January 3, 2009
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomesAmanda Nickles Fader, Christa Nagel, Allison E Axtell, et al.
Gynecologic Oncology|January 15, 2019
Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trialMichel Fabbro, Kathleen N Moore, Anne Dørum, et al.
Gynecologic Oncology|April 26, 2025
Impact of adding the immune checkpoint inhibitor atezolizumab to first-line chemotherapy on progression-free survival in poor-prognosis ovarian cancer: A retrospective analysis from the IMagyn050 trialBenoit You, Charles Anderson, Sabrina Chiara Cecere, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Zarna Rajeshkumar Pala, Thiago Luiz Alves E Silva, Mahnaz Minai, et al.
Frontiers in Pharmacology|May 1, 2024
The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat modelAmy L Inselman, Elysia A Masters, Jalina N Moore, et al.
Frontiers in Oncology|February 28, 2022
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b StudySara M Tolaney, Muralidhar Beeram, J Thaddeus Beck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2020
Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 TrialPaul DiSilvestro, Nicoletta Colombo, Giovanni Scambia, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 17, 2023
Low-grade serous ovarian cancer: expert consensus report on the state of the scienceRachel N Grisham, Brian M Slomovitz, Nicole Andrews, et al.
Pageof 143